EnCor Biotechnology
EnCor Biotechnology is a biotechnology company that specializes in the development and production of antibodies and proteins for use in research, diagnostics, and therapeutics. The company is known for its innovative approaches to protein engineering and antibody production, and has a strong focus on neuroscience and neurodegenerative diseases.
History
EnCor Biotechnology was founded in the late 1990s by a group of scientists with a shared interest in understanding and treating neurodegenerative diseases. The company has since grown to become a leading provider of antibodies and proteins to the research community.
Products and Services
EnCor Biotechnology offers a wide range of products and services, including:
- Monoclonal antibodies: These are antibodies that are made by identical immune cells that are all clones of a unique parent cell. They have monovalent affinity, in that they bind to the same epitope.
- Polyclonal antibodies: These are derived from different B cell lineages. They are usually a mix of different plasma cells.
- Recombinant proteins: These are proteins that are produced through recombinant DNA technology. This involves the introduction of a DNA sequence coding for a protein into a host organism, where it is then expressed and a protein is produced.
- Peptide synthesis: This is the production of peptides, which are short chains of amino acid monomers linked by peptide bonds.
- Custom antibody production: This is a service where the company produces antibodies to a specific antigen as per the customer's requirements.
Research and Development
EnCor Biotechnology is heavily involved in research and development, with a particular focus on neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. The company's research efforts are aimed at understanding the underlying mechanisms of these diseases and developing effective treatments.
See Also
References
External Links
EnCor_Biotechnology
- Encor-biotechnology-logo.jpg
EnCor Biotechnology Logo
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD